Of course, future studies will be required to better explain these results and to clarify the mechanistic functions of ALPL, GPR68, NETO1, and VGF in the GBM TME and how they can mediate the success of CW application in the tumor resection cavity. The gene discussed is GPR68; the disease is glioblastoma.